Drug intelligence / Profile preview

Da Shanzha Wan

Development stage: Unknown
Lead developer: Henan Jindan Lactic Acid Technology
Administration: Oral

Overview

Da Shanzha Wan is a traditional Chinese medicine (TCM) formula produced by Liaoning Jindan Pharmaceutical, primarily used as a digestive aid. It is composed of three main herbal ingredients: Hawthorn (*Crataegus pinnatifida* fruit), Medicated Leaven (*Massa Medicata Fermentata*), and Malt (*Hordeum vulgare* malt). The formula is traditionally used to treat food stagnation, manifesting as indigestion, abdominal fullness, and loss of appetite, particularly after consuming heavy or greasy meals. Pharmacologically, it is thought to stimulate the secretion of gastric acid and pepsin, thereby facilitating the breakdown of proteins and fats and improving gastrointestinal motility.

Brand names: Da Shanzha Wan
Other names: Big Hawthorn PillDashanzha Wan

Beyond the preview

Go deeper on Da Shanzha Wan.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Da Shanzha Wan.

Explore the full profile